|According to the scientists, the university and the Ural Branch of the Russian Academy of Sciences are developing world-class materials.
Photo credit: TASS-Ural Press Center, Vladislav Burnashev
Scientists from the Ural Federal University and the Postovsky Institute of Organic Synthesis have developed a drug to combat post-covidal complications, namely, the formation of blood clots. The drug blocks the release of clot-forming compounds caused by coronavirus infection. As the scientists point out, this is a world-class achievement, as new classes of compounds capable of combating the effects of coronavirus have been discovered. Representatives of the Ural Branch of the Russian Academy of Sciences talked about this, as well as about other developments aimed at ensuring the scientific and technological sovereignty of Russia, at a press conference at TASS.
"We develop unique things. This is important to note, because now the concept of import substitution is pushed to the background, and we are talking about the scientific and technological sovereignty of the country. The fact is that import substitution implies reproduction, copying of foreign technologies. We are catching up beforehand. Scientific and technological sovereignty implies independence from external conditions and supremacy in the development of industrial samples and new materials which are superior to foreign analogues in their characteristics. Therefore, it is certain that the Ural scientists successfully solve the task of ensuring scientific and technological progress," emphasizes Victor Rudenko, Academician and Chairman of the Ural Branch of the Russian Academy of Sciences.
Representatives of the Ural Branch of the Russian Academy of Sciences note the high degree of integration between the academy and the university. In addition to new drugs, researchers collaborating at Ural Interregional Research and Education Center create new materials and technologies, for example, for the steel industry. Together with Chinese colleagues, scientists create antiviral drugs, and with representatives of Belgium they develop new methods of CH-functionalization of organic compounds. Valery Charushin, Professor of the Department of Organic and Biomolecular Chemistry at Ural Federal University and Chair of the Joint Academic Council for Chemical Sciences of the Ural Branch of the Russian Academy of Sciences, adds that this is a fundamental area of study that has gained world recognition. In addition, Ural scientists have achieved high results in organic electronics.
Several laboratories and centers have been opened at the university in cooperation with the Ural Branch of the Russian Academy of Sciences, including for testing technological processes that allow transferring scientific discoveries to the industrial scale. In the future, cooperation between the university and the Academy of Sciences will only expand.
Source/Credit: Ural Federal University